SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen
BIIB 167.63+1.8%Nov 14 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (764)10/7/1998 9:43:00 AM
From: Harold Engstrom  Read Replies (1) of 1686
 
Thanks for the good wishes Rick. And thanks to Hong-Lee Yu for the good analysis a couple of posts back.

Biogen is in for a great run. The company is on a great course. LFA3TIP and 5C8 hold great promise. But CVT124 and VLA4 aren't bad either. Hirulog will be a bit of icing on the cake at some point. But, the best news was another compound on its way out of the pre-clinical stage. Am very impressed that the company continues to do great science and to handle clinical trials, manufacturing, marketing and distribution very well simultaneously.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News